All about health

Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, announced today treatment results from OVERTURE II, an open-label extension (OLE) study of Spectristm, a potential disease modifying therapy...

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Jeffrey Trigilio as Chief Financial Officer, effective May 1, 2024. "We are thrilled to welcome...

UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the U.S. Food and Drug Administration (FDA) accepted the Company's Investigational New...

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief Business Officer, solidifying KBI's Executive...

It was an evening filled with 70s disco flair, delicious canapés, and thrilling prizes to be won. The Montreal Airport Marriott In-Terminal Hotel was converted into Studio 514, a unique Montreal-spin on the famed disco nightclub Studio 54. It was a...

Organovo Holdings, Inc. , a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today released the complete details of its 16-week,...

Microbion Corporation today announced that the company has been selected to present topical pravibismane for the treatment of diabetic foot infection (DFI) at the Advanced Wound Care Summit USA held at the Boston Marriot Long Wharf from April 16th to...

Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, has announced the completion of three batches of its MDMA Active...

Vasomune Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases associated with vascular dysfunction, has been selected by the American Thoracic Society to...

Patients are being threatened with extremely long wait times, denied vital procedure information, and coerced or manipulated into paying for unnecessary add-ons at for-profit surgical and diagnostic clinics. The extra charges for medically necessary...

Extendicare Inc. ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of April 2024, which is payable on May 15, 2024 to shareholders of record...

London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and predictable PK parameters. CBDS maintains improved oral formulation...

Wound Care Plus, LLC, a leading provider of mobile wound care services in the US, has announced a groundbreaking partnership with ARANZ Medical to integrate ARANZ Medical's innovative Silhouette wound assessment solution into their wound care...

BrainCheck, Inc., a digital health innovator delivering next-generation technology into the growing digital cognitive assessment market, will exhibit its comprehensive cognitive assessment platform in booth #834 at the American Academy of Neurology...

Professor Julia Scarisbrick of University of Birmingham on Friday, April 12, 2024, presented interim findings from the Kyowa Kirin, Inc. (Kyowa Kirin, TSE: 4151)-sponsored study, "Real-World Observational Study of Mogamulizumab in Adult Patients with...

Fluence, a global leader in education, training, and certification for practitioners of psychedelic medicine, and Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to pushing the boundaries of...

Neurvati Neurosciences, a clinical-stage biotechnology company dedicated to bringing a new generation of proven-effective therapies to people affected by neurological and psychiatric disorders, today announced the appointment of Dr. Deborah Dunsire...

Viatris Inc. , a global healthcare company, today announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company's Executive Leadership Team, effective today. Le Goff is an accomplished...

GT Medical Technologies, Inc. (GT MedTech) announces the successful acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc. This acquisition solidifies GT MedTech's position as sole...

Numinus sharpens its focus on streamlining operations and maximizing shareholder returns through a focus on U.S. operations and strategic adjustments in its Canadian market presence.Focusing on the Numinus Network in Canada, a resource-efficient,...

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the global achievement of more than...

Zai Lab Limited today announced that it will report financial results for the first quarter of 2024 and recent corporate updates, after the closing of the U.S. equity markets on Wednesday, May 8, 2024. The Company will host a live conference call...

Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it has appointed Todd West as Chief Operating Officer ("COO"), effective April 12, 2024. Mr. West brings over 25 years of...

Canopy Growth Corporation ("Canopy Growth" or the "Company") today announced the voting results from its...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Office of Orphan Products...

ADAMA Ltd. (SZSE: 000553), a leading crop protection company, announced the launch of Maganic®, a new T3 fungicide for European cereal growers that protects wheat against all ear diseases resulting in healthy crops, higher yields, lower mycotoxin...

AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that the first patient has been treated in the Phase 1/2 ASPIRE-FTD trial...

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that Biomedicines published an article titled "Namodenoson at the...

Neo7Bioscience, at the forefront of molecular research, assumes a pivotal role in a transformative collaboration with Serokell, a leading AI development company, and Elsevier, the developer of the knowledge graph and a leading provider of scientific...

Labcorp , a global leader of innovative and comprehensive laboratory services, today announced the availability of the nation's first test for glial fibrillary acidic protein (GFAP), a critical blood-based biomarker for the early detection of...